In court on March 13th the Xechem attorney said that the company's plan is to create a derivative of Nicosan and work on funding for clinical trials for that. That was the extent of it...
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.